Legislative Strategy for Virginia Cannabis Market Regulation
Following Virginia Governor Spanberger’s veto of legislation to establish a regulated adult-use cannabis market, state lawmakers are now considering an alternative path: integrating these provisions into the upcoming budget bill. This approach could potentially bypass the governor’s previous objections and advance according to Marijuana Moment.
Senate Majority Leader Scott Surovell (D), who also chairs the Courts of Justice Committee, indicated that the issue of cannabis retail sales is not concluded for the year. He stated that policy measures, such as those pertaining to the Virginia cannabis market regulation, can be incorporated into the budget and presented to the governor. Senate President Pro Tempore Louise Lucas (D) echoed this sentiment, highlighting that the governor’s vetoes have impacted potential state revenue. Lucas suggested the governor could submit new bills to address vetoes and restore anticipated funds.
Lawmakers are scheduled to reconvene in June to finalize the budget, which must be passed by July 1. Finalizing the legislation close to this deadline could compel the governor to sign the budget, even if it contains provisions she previously opposed, to avert a state government shutdown.
Governor’s Stance and Policy Concerns
Governor Spanberger has expressed reservations about lawmakers embedding cannabis sales provisions within the budget. Speaking to The Richmond Times-Dispatch, she described such a tactic as an “outrageous possibility” and an “abuse of the process,” indicating that many legislators she had consulted also opposed it. The governor maintained that the original bills, SB 542 and HB 642, were not adequately prepared for implementation.
Her veto last week followed the legislature’s rejection of her proposed amendments to the cannabis sales bills. These amendments included:
- Delaying the start date for legal sales from January 1, 2027, to July 1, 2027.
- Increasing the excise tax from 6 percent to 8 percent starting July 1, 2029.
- Instituting new criminal penalties for cannabis consumers, such as making public marijuana use a Class 4 criminal misdemeanor (instead of a $25 civil fine) and possessing cannabis under 21 a Class 1 misdemeanor with mandatory fines or community service.
- Redirecting all cannabis revenue to the general fund, rather than specific allocations for the Cannabis Equity Reinvestment Fund, early childhood education, and behavioral health services.
- Eliminating legislative study of on-site consumption licenses and microbusiness event permits.
The governor also cited concerns about a “rushed timeline” for market establishment and the potential for “far more stores across Virginia” than she deemed appropriate. She previously signed legislation providing resentencing relief for individuals with past cannabis convictions and allowing patients to access medical cannabis in hospitals, indicating support for some cannabis reforms.
Industry and Advocacy Perspectives
Industry stakeholders and advocacy groups have continued to press for the establishment of a regulated Virginia cannabis market. JM Pedini, development director for NORML and executive director for Virginia NORML, stated that claims of the state being unprepared are unfounded, given the six legislative sessions dedicated to the debate. Pedini affirmed NORML’s commitment to exploring all options to finalize market regulation in 2026.
Trent Woloveck, Chief Strategy Officer at cannabis company Jushi, expressed hope for a compromise during the special session, noting that the differences between the legislature’s bill and the governor’s proposed substitute were not substantial. A coalition of cannabis reform organizations, including Virginia NORML, Marijuana Justice, and the Marijuana Policy Project, had previously sent a letter to Governor Spanberger urging her not to veto the sales legalization legislation. The letter emphasized that a regulated market would replace existing illicit operations with a framework of enforceable rules, oversight, product safeguards, and consumer safety standards, similar to those already in place for medical cannabis in Virginia.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
